Odegard PS, Goo A., Hummel J., Williams KL, Gray SLCaring for poorly controlled diabetes: a randomized pharmacist intervention . Ann Pharmacother. 2005;39(3):433-440.
2.
Morisky DE, Green LW, Levine DMConcurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
3.
Svarstad BL, Chewning BA, Sleath BL, Claesson C.The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999; 37(2):113-124.
4.
Centers for Disease Control and Prevention.National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.
5.
Saaddine JB, Cadwell B., Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144:465-474.
6.
Rhee MK, Slocum W., Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educ. 2005;31(2):240-250.
7.
Krapek K., King K., Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmaco. 2004;38:1357-1362.
8.
Schectman JM , Nadkarni MM, Voss JDThe association between diabetes metabolic control and drug adherence in an indigent population. Diab Care. 2002;25:1015-1021.
9.
Donnan PT, MacDonald TM, Morris AD, for the DARTS/MEMO Collaboration.Adherence to prescribed oral hypoglycemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19:279-282.
10.
Evans JM, Donnan PT, Morris ADAdherence to oral hypoglycemic agents prior to insulin therapy in type 2 diabetes . Diabet Med. 2002;19:685-688.
11.
Venturini F. , Nichol MB, Sung JC, Bailey KL, Cody M., McCombs JSCompliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999; 33(Mar):281-288.
12.
Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RWAdherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet. 1997;350(Nov):1505-1510.
13.
Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CESulfonylurea pharmacotherapy regimen compliance in a Medicaid population: influence of age, gender, and race. Diabetes Educ. 1999;25(4):531-538.
14.
Newman KD, Weaver MTInsulin measurement and preparation among diabetic patients at a county hospital . Nurse Pract. 1994;19(3):44-45, 48.
15.
Hertz RP, Unger AN, Lustik APAdherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27(7): 1064-1073.
16.
Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-1841.
17.
American Diabetes Association.Direct and indirect costs of diabetes in the United States. Available at: http://www.diabetes.org/diabetes-statistics/cost-of-diabetes-in-us.jsp . Accessed July 25, 2007.
18.
Rubin RRAdherence to pharmacologic therapy in patients with type 2 diabetes mellitus . Am J Med. 2005;188(5A):27S-34S.
19.
Lin EH, Katon W., Von Korff M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diab Care. 2004;27(9):2154-2160.
20.
Paes AHP , Bakker A., Soe-Agnie CJImpact of dosage frequency on patient compliance . Diab Care . 1997;20(10):1512-1517.
21.
Grant RW, Devita NG, Singer DE, Meigs JBPolypharmacy and medication adherence in patients with type 2 diabetes . Diab Care. 2003:26(5):1408-1412.
22.
Hartz A., Kent S., James P., Xu Y., Kelly M., Daly J.Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2006;74:227-232.
23.
Richter A., Anton SE, Koch P., Dennett SLThe impact of reducing dose frequency on health outcomes. Clin Therap. 2003; 25(8):2307-2335.
